SCHEMBL30484109

SCHEMBL30484109

Clc1ncnc2[nH]c3cc(Br)ccc3c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.54
RET P07949 1/20 0.45
EGFR P00533 2/20 0.44
PDPK1 O15530 1/20 0.41
JAK2 O60674 1/20 0.41
LMNA P02545 3/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
BRD4 O60885 1/20 0.40
GSK3B P49841 4/20 0.40
ABL1 P00519 1/20 0.38
ABL2 P42684 1/20 0.38
ERBB2 P04626 1/20 0.38
PTK6 Q13882 1/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
CCNT1 O60563 1/20 0.38
CCNB2 O95067 1/20 0.38
CCNE2 O96020 1/20 0.38
CDK1 P06493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6883079 1.00 AURKA (0.54) AURKARETEGFRPDPK1JAK2
SCHEMBL23852137 0.87 AURKA (0.54) AURKAEGFRPDPK1JAK2LMNA
SCHEMBL30051967 0.82 PDPK1 (0.50) RETEGFRPDPK1JAK2GSK3B
SCHEMBL23885373 0.82 PDPK1 (0.50) RETEGFRPDPK1JAK2GSK3B
SCHEMBL31705976 0.81 AURKA (0.54) AURKAEGFRLMNAMAPTSMN1; SMN2
SCHEMBL6881163 0.81 AURKA (0.57) AURKARETEGFRLMNAMAPT
SCHEMBL6881565 0.81 EGFR (0.44) RETEGFRPDPK1JAK2GSK3B
SCHEMBL23863268 0.77 AURKA (0.57) AURKAEGFRLMNAMAPTSMN1; SMN2
SCHEMBL17204317 0.77 BRD4 (0.43) PDPK1JAK2BRD4GSK3BERBB2
SCHEMBL3113184 0.77 AURKA (0.50) AURKARETEGFRLMNABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025217212-A1 MAC1 INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-10-16 WO disclosed
EP-4457230-A1 DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BeiGene Switzerland GmbH (CH) 2024-11-06 EP disclosed
CN-118894861-A Novel tricyclic compounds as IRAK4 inhibitors 韩国化学研究院 2024-11-05 CN disclosed
CN-118414336-A Degradation of Bruton Tyrosine Kinase (BTK) by conjugation of BTK inhibitors to E3 ligase ligands and methods of use 百济神州有限公司 2024-07-30 CN disclosed
CN-113227095-B Novel tricyclic compounds as IRAK4 inhibitors 韩国化学研究院 2024-07-05 CN disclosed
WO-2023125907-A1 DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2023-07-06 WO disclosed